home / stock / inno:cc / inno:cc news

INNO:CC News and Press, Innocan Pharma Corporation - Common Shares From 03/12/23

Stock Information
Company Name: Innocan Pharma Corporation - Common Shares
Stock Symbol: INNO:CC
Market: CNQC
Website: innocanpharma.com
Menu
INNO:CC INNO:CC Quote INNO:CC Short INNO:CC News INNO:CC Articles INNO:CC Message Board
Get INNO:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
INNO:CC - Innocan Pharma Announces First Patent Grant in the United States

This is the first fully granted patent of Innocan in the United States The Patent covers Innocan's proprietary cannabis-based pain relief topical This serves as an indication of Innocan's growing intellectual property portfolio Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 1...
INNO:CC - Innocan Pharma Reports Clinical Success in Canine Compassionate Care Trial

"Lady", an 11-year-old female dog was presented to Innocan labs suffering from severe autoimmune mediated polyarthritis. Lady was treated with Glycoflex, steroids, and hydrotherapy, but still suffered pain and had difficulty walking more than a few steps. Lady was administered Innocan's liposom...

INNO:CC - Innocan Pharma Provides Annual "State of the Business" Update

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - February 16, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a prop...

INNO:CC - Innocan Pharma Signs a First Consulting Agreement to Commercialize its Pharmaceutical IP in the Veterinary Field

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - December 2, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies, is pleased to anno...
INNO:CC - Innocan Pharma Reports Q3 2022 Results with 700% Increase in Revenues Compared to Q3 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 29, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a p...

INNO:CC - Mr. Givi Topchishvili to Join Innocan Pharma's Advisory Committee

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 18, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a ...

INNO:CC - Canadian Securities Exchange Reports October 2022 Performance Figures

Global Business Development Efforts Continue in Las Vegas and Israel Toronto, Ontario--(Newsfile Corp. - November 15, 2022) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of October 2022. October 2022 Operating Statistics ...
INNO:CC - Innocan Pharma Goes Live with Priority(TM) ERP System

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - November 9, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a pr...

INNO:CC - Innocan Pharma to Participate in IR Labs' Investor Webinar on November 2, 2022

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 25, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a pr...

INNO:CC - Innocan Pharma to Participate in the Luxury Meets CBD Conference on October 20 & 21 in New York

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - October 13, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) a pharmaceutical tech company focusing on developing innovative drug delivery platform technolo...
Previous 10 Next 10